Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective

Chronic hepatitis C remains one of the main causes of chronic liver disease worldwide and presents a variable natural history ranging from minimal changes to advanced fibrosis and cirrhosis and its complications, such as development of hepatocellular carcinoma. Approximately, 1.45 million people are...

Full description

Saved in:
Bibliographic Details
Main Authors: Rodolfo Castro, Hugo Perazzo, Beatriz Grinsztejn, Valdilea G. Veloso, Chris Hyde
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:International Journal of Hepatology
Online Access:http://dx.doi.org/10.1155/2015/852968
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850109473178255360
author Rodolfo Castro
Hugo Perazzo
Beatriz Grinsztejn
Valdilea G. Veloso
Chris Hyde
author_facet Rodolfo Castro
Hugo Perazzo
Beatriz Grinsztejn
Valdilea G. Veloso
Chris Hyde
author_sort Rodolfo Castro
collection DOAJ
description Chronic hepatitis C remains one of the main causes of chronic liver disease worldwide and presents a variable natural history ranging from minimal changes to advanced fibrosis and cirrhosis and its complications, such as development of hepatocellular carcinoma. Approximately, 1.45 million people are estimated to be infected by HCV in Brazil representing a major public health issue. The aim of this paper was to review the epidemiology and management of chronic hepatitis C from a Brazilian perspective. The management of chronic hepatitis C has been challenged by the use of noninvasive methods to stage liver fibrosis as an alternative to liver biopsy and the high cost of new interferon-free antiviral treatments. Moreover, the need of cost-effectiveness analysis in hepatitis C and the recent changes in treatment protocols were discussed.
format Article
id doaj-art-4abedd02a0494f9cb701f15ea03419b4
institution OA Journals
issn 2090-3448
2090-3456
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series International Journal of Hepatology
spelling doaj-art-4abedd02a0494f9cb701f15ea03419b42025-08-20T02:38:03ZengWileyInternational Journal of Hepatology2090-34482090-34562015-01-01201510.1155/2015/852968852968Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian PerspectiveRodolfo Castro0Hugo Perazzo1Beatriz Grinsztejn2Valdilea G. Veloso3Chris Hyde4Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Laboratory of Clinical Research on STD/AIDS, Avenida Brasil 4365, 21040-900 Manguinhos, RJ, BrazilEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Laboratory of Clinical Research on STD/AIDS, Avenida Brasil 4365, 21040-900 Manguinhos, RJ, BrazilEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Laboratory of Clinical Research on STD/AIDS, Avenida Brasil 4365, 21040-900 Manguinhos, RJ, BrazilEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Laboratory of Clinical Research on STD/AIDS, Avenida Brasil 4365, 21040-900 Manguinhos, RJ, BrazilInstitute of Health Research, Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis and Modelling for Health Improvement (ESMI), University of Exeter Medical School, University of Exeter, St Luke’s Campus, South Cloisters, Exeter EX1 2LU, UKChronic hepatitis C remains one of the main causes of chronic liver disease worldwide and presents a variable natural history ranging from minimal changes to advanced fibrosis and cirrhosis and its complications, such as development of hepatocellular carcinoma. Approximately, 1.45 million people are estimated to be infected by HCV in Brazil representing a major public health issue. The aim of this paper was to review the epidemiology and management of chronic hepatitis C from a Brazilian perspective. The management of chronic hepatitis C has been challenged by the use of noninvasive methods to stage liver fibrosis as an alternative to liver biopsy and the high cost of new interferon-free antiviral treatments. Moreover, the need of cost-effectiveness analysis in hepatitis C and the recent changes in treatment protocols were discussed.http://dx.doi.org/10.1155/2015/852968
spellingShingle Rodolfo Castro
Hugo Perazzo
Beatriz Grinsztejn
Valdilea G. Veloso
Chris Hyde
Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective
International Journal of Hepatology
title Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective
title_full Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective
title_fullStr Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective
title_full_unstemmed Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective
title_short Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective
title_sort chronic hepatitis c an overview of evidence on epidemiology and management from a brazilian perspective
url http://dx.doi.org/10.1155/2015/852968
work_keys_str_mv AT rodolfocastro chronichepatitiscanoverviewofevidenceonepidemiologyandmanagementfromabrazilianperspective
AT hugoperazzo chronichepatitiscanoverviewofevidenceonepidemiologyandmanagementfromabrazilianperspective
AT beatrizgrinsztejn chronichepatitiscanoverviewofevidenceonepidemiologyandmanagementfromabrazilianperspective
AT valdileagveloso chronichepatitiscanoverviewofevidenceonepidemiologyandmanagementfromabrazilianperspective
AT chrishyde chronichepatitiscanoverviewofevidenceonepidemiologyandmanagementfromabrazilianperspective